Top

Published in:

01-11-2013 | Original Article

Is Colonoscopic Screening Necessary for Patients with Gastric Adenoma or Cancer?

Authors: Seung Young Kim, Sung Woo Jung, Jong Jin Hyun, Ja Seol Koo, Rok Seon Choung, Hyung Joon Yim, Sang Woo Lee, Jai Hyun Choi

Published in: Digestive Diseases and Sciences | Issue 11/2013

Abstract

Background

Since colorectal adenoma or cancer is commonly associated with gastric adenoma or cancer, early colorectal adenoma detection can affect the survival of gastric adenoma or cancer patients.

Aims

The purpose here was to investigate the colorectal adenoma or cancer prevalence and evaluate the necessity for screening colonoscopy in gastric adenoma or cancer patients.

Patients and methods

From September 2005 through August 2010, 857 patients younger than 70 years who had gastric adenoma or cancer were enrolled. Healthy age- and sex-matched controls were selected from the general screening population. The prevalence and risk of colorectal adenoma or cancer were compared between the participants and the controls.

Results

Data from 416 patients in the gastric neoplasm group (123 with gastric adenoma and 293 with gastric cancer) and 416 healthy control group participants were included in the statistical analysis. The presence of gastric adenoma or cancer was an independent risk factor for colorectal neoplasm (OR = 1.348, 95 % CI = 1.001–1.815). Patients with diffuse type gastric cancer had a lower prevalence of colorectal adenoma or cancer than those with gastric adenoma or intestinal type cancer. In gastric cancer patients younger than 50 years, intestinal type histology was significantly associated with colorectal adenoma or cancer (OR = 3.838, 95 % CI = 1.077–13.677).

Conclusions

The colorectal adenoma or cancer risk was significantly increased in patients with gastric adenoma or cancer. Therefore, screening colonoscopy should be considered for gastric adenoma or cancer patients including young patients, in the case of intestinal type gastric cancer.

Jung KW, Park S, Won YJ, et al. Prediction of cancer incidence and mortality in Korea, 2011. Cancer Res Treat. 2011;43:12–18.PubMedCrossRef

Kang KJ, Lee JH. Characteristics of gastric cancer in Korea—with an emphasis on the increase of the early gastric cancer (EGC). J Korean Med Assoc. 2010;53:283–289.CrossRef

Kim HO, Hwang SI, Yoo CH, Kim H. Preoperative colonoscopy for patients with gastric adenocarcinoma. J Gastroenterol Hepatol. 2009;24:1740–1744.PubMedCrossRef

Mizoue T, Yoshimura T, Tokui N, et al. Prospective study of screening for stomach cancer in Japan. Int J Cancer. 2003;106:103–107.PubMedCrossRef

Tan YK, Fielding JW. Early diagnosis of early gastric cancer. Eur J Gastroenterol Hepatol. 2006;18:821–829.PubMedCrossRef

Ikeguchi M, Ohfuji S, Oka A, Tsujitani S, Maeda M, Kaibara N. Synchronous and metachronous primary malignancies in organs other than the stomach in patients with early gastric cancer. Hepatogastroenterology. 1995;42:672–676.PubMed

Eom BW, Lee HJ, Yoo MW, et al. Synchronous and metachronous cancers in patients with gastric cancer. J Surg Oncol. 2008;98:106–110.PubMedCrossRef

Ikeda Y, Saku M, Kawanaka H, Nonaka M, Yoshida K. Features of second primary cancer in patients with gastric cancer. Oncology. 2003;65:113–117.PubMedCrossRef

Lee JH, Bae JS, Ryu KW, et al. Gastric cancer patients at high-risk of having synchronous cancer. World J Gastroenterol. 2006;12:2588–2592.PubMed

10.

Lim SB, Jeong SY, Choi HS, et al. Synchronous gastric cancer in primary sporadic colorectal cancer patients in Korea. Int J Colorectal Dis. 2008;23:61–65.PubMedCrossRef

11.

Arai T, Sawabe M, Takubo K, Kanazawa K, Esaki Y. Multiple colorectal cancers in the elderly: a retrospective study of both surgical and autopsy cases. J Gastroenterol. 2001;36:748–752.PubMedCrossRef

12.

Ueno M, Muto T, Oya M, Ota H, Azekura K, Yamaguchi T. Multiple primary cancer: an experience at the Cancer Institute Hospital with special reference to colorectal cancer. Int J Clin Oncol. 2003;8:162–167.PubMedCrossRef

13.

Yamamoto S, Yoshimura K, Ri S, Fujita S, Akasu T, Moriya Y. The risk of multiple primary malignancies with colorectal carcinoma. Dis Colon Rectum. 2006;49:S30–S36.PubMedCrossRef

14.

Bae RC, Jeon SW, Cho HJ, Jung MK, Kweon YO, Kim SK. Gastric dysplasia may be an independent risk factor of an advanced colorectal neoplasm. World J Gastroenterol. 2009;15:5722–5726.PubMedCrossRef

15.

Park SY, Kim HS, Yoon KW, et al. Prevalence of colorectal adenoma is increased in patients with gastric adenoma. Korean J Gastroenterol. 2009;54:220–226.PubMedCrossRef

16.

Yang MH, Son HJ, Lee JH, et al. Do we need colonoscopy in patients with gastric adenomas? The risk of colorectal adenoma in patients with gastric adenomas. Gastrointest Endosc. 2010;71:774–781.PubMedCrossRef

17.

Zauber AG, Winawer SJ, O’Brien MJ, et al. Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths. N Engl J Med. 2012;366:687–696.PubMedCrossRef

18.

Lauren P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand. 1965;64:31–49.PubMed

19.

Joo MK, Park JJ, Lee WW, et al. Differences in the prevalence of colorectal polyps in patients undergoing endoscopic removal of gastric adenoma or early gastric cancer and in healthy individuals. Endoscopy. 2010;42:114–120.PubMedCrossRef

20.

Oh SY, Park DI, Yoo TW, et al. Is gastric cancer a new indication for surveillance colonoscopy? Colon cancer is increased in gastric cancer patients. Korean J Gastroenterol. 2006;47:191–197.PubMed

21.

Park DI, Park SH, Yoo TW, et al. The prevalence of colorectal neoplasia in patients with gastric cancer: a Korean Association for the Study of Intestinal Disease (KASID) Study. J Clin Gastroenterol. 2010;44:102–105.PubMedCrossRef

22.

Yang P, Zhou Y, Chen B, et al. Overweight, obesity and gastric cancer risk: results from a meta-analysis of cohort studies. Eur J Cancer. 2009;45:2867–2873.PubMedCrossRef

23.

Jung MK, Jeon SW, Cho CM, et al. Hyperglycaemia, hypercholesterolaemia and the risk for developing gastric dysplasia. Dig Liver Dis. 2008;40:361–365.PubMedCrossRef

24.

Yamagata H, Kiyohara Y, Nakamura S, et al. Impact of fasting plasma glucose levels on gastric cancer incidence in a general Japanese population: the Hisayama study. Diabetes Care. 2005;28:789–794.PubMedCrossRef

25.

Miyoshi E, Haruma K, Hiyama T, et al. Microsatellite instability is a genetic marker for the development of multiple gastric cancers. Int J Cancer. 2001;95:350–353.PubMedCrossRef

26.

Nakatsuru S, Yanagisawa A, Ichii S, et al. Somatic mutation of the APC gene in gastric cancer: frequent mutations in very well differentiated adenocarcinoma and signet-ring cell carcinoma. Hum Mol Genet. 1992;1:559–563.PubMedCrossRef

27.

Uchino S, Noguchi M, Ochiai A, Saito T, Kobayashi M, Hirohashi S. p53 mutation in gastric cancer: a genetic model for carcinogenesis is common to gastric and colorectal cancer. Int J Cancer. 1993;54:759–764.PubMedCrossRef

28.

Uchino S, Tsuda H, Noguchi M, et al. Frequent loss of heterozygosity at the DCC locus in gastric cancer. Cancer Res. 1992;52:3099–3102.PubMed

29.

Ohtani H, Yashiro M, Onoda N, et al. Synchronous multiple primary gastrointestinal cancer exhibits frequent microsatellite instability. Int J Cancer. 2000;86:678–683.PubMedCrossRef

30.

Dominic OG, McGarrity T, Dignan M, Lengerich EJ. American College of gastroenterology guidelines for colorectal cancer screening 2008. Am J Gastroenterol. 2009;104:2626–2629.PubMedCrossRef

31.

Levin B, Lieberman DA, McFarland B, et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology. 2008;134:1570–1595.PubMedCrossRef

32.

Saito S, Hosoya Y, Togashi K, et al. Prevalence of synchronous colorectal neoplasms detected by colonoscopy in patients with gastric cancer. Surg Today. 2008;38:20–25.PubMedCrossRef

33.

Chan AO, Luk JM, Hui WM, Lam SK. Molecular biology of gastric carcinoma: from laboratory to bedside. J Gastroenterol Hepatol. 1999;14:1150–1160.PubMedCrossRef

34.

Stadtländer CT, Waterbor JW. Molecular epidemiology, pathogenesis and prevention of gastric cancer. Carcinogenesis. 1999;20:2195–2208.PubMedCrossRef

35.

Tahara E, Semba S, Tahara H. Molecular biological observations in gastric cancer. Semin Oncol. 1996;23:307–315.PubMed

36.

Correa P. Human gastric carcinogenesis: a multistep and multifactorial process–First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res. 1992;52:6735–6740.PubMed

37.

Solcia E, Fiocca R, Luinetti O, et al. Intestinal and diffuse gastric cancers arise in a different background of Helicobacter pylori gastritis through different gene involvement. Am J Surg Pathol. 1996;20:S8–S22.PubMedCrossRef

38.

Kim HS, Woo DK, Bae SI, Kim YI, Kim WH. Microsatellite instability in the adenoma-carcinoma sequence of the stomach. Lab Invest. 2000;80:57–64.PubMedCrossRef

39.

Smith AM, Watson SA. Gastrin and gastrin receptor activation: an early event in the adenoma-carcinoma sequence. Gut. 2000;47:820–824.PubMedCrossRef

40.

Robertson DJ, Sandler RS, Ahnen DJ, et al. Gastrin, helicobacter pylori, and colorectal adenomas. Clin Gastroenterol Hepatol. 2009;7:163–167.PubMedCrossRef

41.

Triantafillidis JK, Govosdis V, Konstandellou E, et al. Increased fasting serum levels of growth hormone and gastrin in patients with gastric and large bowel cancer. Ann Gastroenterol. 2002;15:72–77.

Title: Is Colonoscopic Screening Necessary for Patients with Gastric Adenoma or Cancer?
Authors: Seung Young Kim
Sung Woo Jung
Jong Jin Hyun
Ja Seol Koo
Rok Seon Choung
Hyung Joon Yim
Sang Woo Lee
Jai Hyun Choi
Publication date: 01-11-2013
Publisher: Springer US
Published in: Digestive Diseases and Sciences / Issue 11/2013
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI: https://doi.org/10.1007/s10620-013-2824-5

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Aims

Patients and methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 11/2013

Polypharmacy and Comorbidity Are Associated with a Lower Early Virologic Response in Hepatitis C Patients Treated with First Generation Protease Inhibitor Triple Therapy: A Preliminary Analysis

Manometric Abnormalities in the Postural Orthostatic Tachycardia Syndrome: A Case Series

The Differential Effects of Statins on the Risk of Developing Pancreatic Cancer: A Case–Control Study in Two Centres in the United Kingdom

Intravenous Albumin Shortens the Duration of Hospitalization for Patients with Hypoalbuminemia and Bleeding Peptic Ulcers: A Pilot Study

Can Serum Fetuin-A Be Regarded as an Inflammatory Marker Among Patients with Familial Mediterranean Fever?

Ursodiol and Colorectal Cancer or Dysplasia Risk in Primary Sclerosing Cholangitis and Inflammatory Bowel Disease: A Meta-Analysis

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials